Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Importin 8 pseudogene 1 (IPO8P1) is classified as a pseudogene related to the importin 8 (IPO8) gene. Pseudogenes do not encode functional proteins and, in general, are not involved in active biological processes, are not associated with disease, and are not the focus of drug targeting. IPO8P1 is therefore not considered a receptor, enzyme, transporter, or therapeutic target. The functional and therapeutically relevant importin is Importin 8 (IPO8), a member of the karyopherin-β family, functioning in nuclear-cytoplasmic transport. However, IPO8P1, as a pseudogene, does not encode a functional protein and has no known biological role or disease association. No drugs, biomarkers, or clinical implications are reported for IPO8P1. Any search intent involving receptor or drug target properties should focus on IPO8, not IPO8P1. There is no evidence in the current literature or databases that IPO8P1 is a protein, therapeutic target, or has any biological function. Thus, the information submitted may arise from a mislabeling or data confusion with IPO8. If you require structured information on the protein-coding gene, use "Importin 8 (IPO8)" as the query term.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Importin 8 pseudogene 1 (IPO8P1).